CG Oncology (CGON) Shareholder's Equity (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 595,226.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 14.38 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 19.36 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 31.42 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.08 Bn
10 CG Oncology 5.01 Bn 5.01 Bn -1.88 Mn 1.09 Bn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.09 Bn
Dec 31, 2025 752.60 Mn
Sep 30, 2025 687.64 Mn
Jun 30, 2025 670.36 Mn
Mar 31, 2025 704.76 Mn
Dec 31, 2024 733.38 Mn
Sep 30, 2024 536.77 Mn
Jun 30, 2024 552.36 Mn
Mar 31, 2024 568.94 Mn
Dec 31, 2023 -123.10 Mn
Sep 30, 2023 -107.58 Mn
Jun 30, 2023 -97.39 Mn
Mar 31, 2023 -86.12 Mn